Back
Nexstar Media Group Vs. Keros Therapeutics Industry Stock Comparison
Buy
56
NXST
Nexstar Media Group
Last Price:
170.34
Seasonality Move:
10.14%
Buy
68
KROS
Keros Therapeutics
Last Price:
59.23
Seasonality Move:
45.94%
Buy
56
Nexstar Media Group (NXST)
is a Buy
Is Nexstar Media Group a Buy, Sell or Hold?
- The current Nexstar Media Group [NXST] share price is $170.38. The Score for NXST is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- NXST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $59.33. The Score for KROS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NXST Stock Price Chart
What is Nexstar Media Group's stock price today?
-
The Nexstar Media Group share price today is $170.38
The current trend is moderately bullish and NXST is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $59.33
The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
NXST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.39 | Buy |
| Relative Strength Index (14 RSI): | 56.05 | Buy |
| Chaikin Money Flow: | -181530 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (163.91 - 169.71) | Buy |
| Bollinger Bands (100): | (158.75 - 173.95) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 54.42 | Buy |
| Chaikin Money Flow: | -73900 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.33 - 60.71) | Buy |
| Bollinger Bands (100): | (44.91 - 56.17) | Buy |
NXST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.9 | Buy |
| 20-day SMA: | 166.68 | Buy |
| 50-day SMA: | 165.86 | Buy |
| 200-day SMA: | 166.72 | Buy |
| 8-day EMA: | 169.75 | Buy |
| 20-day EMA: | 167.83 | Buy |
| 50-day EMA: | 167.06 | Buy |
| 200-day EMA: | 165.44 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.18 | Sell |
| 20-day SMA: | 59.23 | Buy |
| 50-day SMA: | 53.7 | Buy |
| 200-day SMA: | 54.65 | Buy |
| 8-day EMA: | 60.13 | Sell |
| 20-day EMA: | 58.89 | Buy |
| 50-day EMA: | 55.53 | Buy |
| 200-day EMA: | 51.4 | Buy |
Nexstar Media Group Earnings Growth & NXST Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.64 per share, and a decrease next year of $8.64 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.47 per share.
Nexstar Media Group Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||